Sadoshima J - Search Results

1

Kuroda J, Sadoshima J. Kuroda J, et al. Among authors: sadoshima j. J Cardiovasc Transl Res. 2010 Aug;3(4):314-20. doi: 10.1007/s12265-010-9184-8. Epub 2010 Mar 31. J Cardiovasc Transl Res. 2010. PMID: 20559780 Free PMC article. Review.

2

Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

Hardt SE, Sadoshima J. Hardt SE, et al. Among authors: sadoshima j. Circ Res. 2002 May 31;90(10):1055-63. doi: 10.1161/01.res.0000018952.70505.f1. Circ Res. 2002. PMID: 12039794 Review.

3

Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload.

Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, Liu J, Vatner DE, Sadoshima J, Vatner SF, Ishikawa Y. Okumura S, et al. Among authors: sadoshima j. Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9986-90. doi: 10.1073/pnas.1733772100. Epub 2003 Aug 6. Proc Natl Acad Sci U S A. 2003. PMID: 12904575 Free PMC article.

4

Neurally-mediated increase in calcineurin activity regulates cardiac contractile function in absence of hypertrophy.

Li J, Yatani A, Kim SJ, Takagi G, Irie K, Zhang Q, Karoor V, Hong C, Yang G, Sadoshima J, Depre C, Vatner DE, West MJ, Vatner SF. Li J, et al. Among authors: sadoshima j. Cardiovasc Res. 2003 Sep 1;59(3):649-57. doi: 10.1016/s0008-6363(03)00471-1. Cardiovasc Res. 2003. PMID: 14499866

5

Negative regulators of cardiac hypertrophy.

Hardt SE, Sadoshima J. Hardt SE, et al. Among authors: sadoshima j. Cardiovasc Res. 2004 Aug 15;63(3):500-9. doi: 10.1016/j.cardiores.2004.03.015. Cardiovasc Res. 2004. PMID: 15276475 Review.

6

Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.

Alcendor RR, Kirshenbaum LA, Imai S, Vatner SF, Sadoshima J. Alcendor RR, et al. Among authors: sadoshima j. Circ Res. 2004 Nov 12;95(10):971-80. doi: 10.1161/01.RES.0000147557.75257.ff. Epub 2004 Oct 14. Circ Res. 2004. PMID: 15486319

7

An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophy.

Zhai P, Galeotti J, Liu J, Holle E, Yu X, Wagner T, Sadoshima J. Zhai P, et al. Among authors: sadoshima j. Circ Res. 2006 Sep 1;99(5):528-36. doi: 10.1161/01.RES.0000240147.49390.61. Epub 2006 Aug 10. Circ Res. 2006. PMID: 16902180

8

Thioredoxin and ventricular remodeling.

Ago T, Sadoshima J. Ago T, et al. Among authors: sadoshima j. J Mol Cell Cardiol. 2006 Nov;41(5):762-73. doi: 10.1016/j.yjmcc.2006.08.006. Epub 2006 Sep 26. J Mol Cell Cardiol. 2006. PMID: 17007870 Free PMC article. Review.

9

Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.

Odashima M, Usui S, Takagi H, Hong C, Liu J, Yokota M, Sadoshima J. Odashima M, et al. Among authors: sadoshima j. Circ Res. 2007 May 11;100(9):1344-52. doi: 10.1161/01.RES.0000265846.23485.7a. Epub 2007 Mar 29. Circ Res. 2007. PMID: 17395874

10

Thioredoxin1 as a negative regulator of cardiac hypertrophy.

Ago T, Sadoshima J. Ago T, et al. Among authors: sadoshima j. Antioxid Redox Signal. 2007 Jun;9(6):679-87. doi: 10.1089/ars.2007.1529. Antioxid Redox Signal. 2007. PMID: 17419666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters